The impact of RAS and BRAF mutations on immunotherapy outcomes in MSI-H/dMMR metastatic colorectal cancer patients: A systematic review and meta-analysis

Category Systematic review
ConferenceEuropean Society For Medical Oncology Congress, ESMO 2025
Year 2025
This article has no abstract
Epistemonikos ID: 809815ade004d358068a5d0280ee181e6a6d0ad2
First added on: May 13, 2026